Answers are grounded in this paper and cite their sources.
Diabetes and depression interact through behavioural, biological, therapeutic, and health-system pathways.Depression is associated with poorer self-management, treatment nonadherence, and complications; diabetes complications, hypoglycaemia fear, pain, financial strain, and treatment burden can in turn sustain depressive symptoms and diabetes distress.This narrative minireview examines how electronic medical records (EMRs) and artificial intelligence (AI) could support integrated care for adults with diabetes in longitudinal clinical-record systems.A targeted evidencemapping approach integrates clinical studies with methodological standards for phenotyping, natural language processing, prediction, causal inference, and clinical evaluation.The central argument is that depression, diabetes distress, treatment burden, social vulnerability, and disengagement are related but non-equivalent constructs.Current evidence supports psychosocial screening and integrated personcentred care.Retrospective EMR-AI studies establish feasibility, but declining externalvalidation performance and limited prospective outcome evidence constrain clinical use.Proposed phenotype-action pathways require temporal anchoring, subgroup calibration, mandatory review of safety-critical signals, and accessible follow-up services.Their value should be tested against combined metabolic and mental-health outcomes, equity, workload, cost, and patient experience, rather than discrimination alone.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: